New Research on : Pharmaceutical Contract Manufacturing Market – Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2012 – 2018 Now at Transparency Market Research

Pharmaceutical Contract Manufacturing MarketThe global pharmaceutical contract manufacturing (PCM) market is believed to hold huge opportunities in the future. With economic constraints in European countries, global pharma manufacturing companies are facing extensive cost containment pressures. As a result, pharmaceutical companies are compelled to explore ways to reduce the cost of drug manufacturing.

Thus, a majority of the global drug companies have begun to outsource their manufacturing facilities. Despite the economic pressures faced by pharma companies worldwide, it is expected that the global PCM market will undergo positive growth in the next five years. However, owing to an economic slow-down in European countries, major pharma and biotechnology companies are set to cut down on their spending, resulting in them approaching contract manufacturers across the world.

Browse Reports @ : http://www.transparencymarketresearch.com/pharmaceutical-contract-manufacturing.html

The global pharmaceutical market is undergoing drastic changes because of factors such as increase in generic market competition, decline in R&D productivity, reduction in patent tenure, and growing government restraints, forcing pharmaceutical and biotechnology companies to reduce drug prices. Moreover, an average drug development process takes ten to fifteen years until the commercialization of such a drug and the cost involved in this process is around USD 1 billion.

With a limited number of blockbuster drugs, it has become necessary for pharmaceutical companies to conduct faster drug development with corresponding cost containment. After the procurement of regulatory approval for the drug, the pharma companies have to meet the short deadlines to deliver the drug in the market in large quantities. This has resulted in outsourcing of manufacturing facilities to PCMs.

Outsourcing of manufacturing activities to PCMs enables pharma companies to focus on its R&D activities and harness the wide service range offered by them. The U.S. is the largest market for PCM followed by Europe. Large scale growth is expected in the Asia-Pacific market owing to development it its industrial infrastructure and increase in the incentives offered by the governments.

The big names in the global PCM market are Althea Technologies. HAUPT Pharma AG, Catalent Pharma Solutions, Jubilant Life Sciences Limited, Dishman Pharmaceuticals and Chemicals Limited, NextPharma, Kemwell Pvt. Ltd., Nipro Corp., and Royal DSM N.V.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Latest Upcoming Pharmaceutical Market Research Reports @ : http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

About Us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact US

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Transparency Market Research Blog @ : 

http://www.tmrmarketresearch.blogspot.com/

Market Research on : Antiemetic Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019 : Now at Transparency Market Research

Antiemetics are therapeutic agents which are used to treat vomiting and nausea caused by several medical conditions. Nausea and vomiting are not diseases, they are symptoms associated with a variety of medical conditions such as gastroenteritis, motion sickness, dizziness, pregnancy, overeating, emotional stress and food poisoning. Nausea is a condition of unease in the stomach with an involuntary desire to vomit, this often occurs before vomiting. Various antiemetics used to treat vomiting and nausea are dolasetron, olanzapine, alizapride, cyclizine, promethazine and lorazepam. Some of the commercially available brands of antiemetics are Phenergan (promethazine) by Baxter Healthcare Corporation and Zyprexa (olanzapine) by Eli Lilly.

Browse Report @ : http://www.transparencymarketresearch.com/antiemetic-drugs-market.html

The market for antiemetics is segmented on the basis of different class of drugs used to treat emesis and nausea such as 5-HT3 receptor antagonists, dopamine antagonists, NK1 receptor antagonists, anticholinergics and others. 5HT3 receptor antagonists act by blocking serotonin receptors in the central nervous system and gastrointestinal tract and comprises of dolastron, ondansetron and tropistron. Dopamine antagonists include domperidone, olanzapine and alizapride while aprepitant and casopitant are NK1 receptor antagonists.

The market for antiemetic drugs is projected to grow worldwide under the influence of increasing incidences of cancer, increased number of surgical procedures being conducted worldwide and other diseases. As mentioned earlier nausea and vomiting are not diseases but they are symptoms and side effects of a variety of diseases including cancer, gastroenteritis, surgeries and early stages of pregnancy. The market of antiemetic drugs will experience along with the increasing incidences of the aforementioned diseases. Nausea is one of the major symptoms caused by motion sickness, if the motion responsible for nausea is not resolved, it will result into vomiting. Extensive travelling causing motion sickness is also one of the major factors driving the growth of the market. The market is growing the fastest in Asia-Pacific due to large number of patients suffering from cancer, gastroenteritis and other diseases causing nausea and vomiting.

Some of the market players in this industry are Pfizer, Baxter International, GlaxoSmithKline, Sanofi, Novartis AG, Merck & Co., Astellas Pharma, Inc., Eli Lilly, Johnson& Johnson, Bristol-Myers Squibb and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Latest Upcoming Pharmaceutical Market Research Reports @ : http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

About Us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact US

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Transparency Market Research Blog @ :

http://www.tmrmarketresearch.blogspot.com/